Browsing items tagged “Jim Lang | EVERSANA”

EVERSANA™ announces an agreement to acquire Cornerstone Research Group; adds global HEOR capabilities to integrated commercial services platform

CHICAGO  – October 30, 2019  – EVERSANA™, the leading independent provider of commercial services to the life science industry, today announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Headquartered in Burlington, Ontario with an additional location in Sydney, Nova Scotia, Cornerstone Research Group is the leader in Health Economics and Outcomes Research (HEOR) […]

EVERSANA™ named a Great Place to Work by global workplace authority

CHICAGO – October 28, 2019 – EVERSANA™, the leading independent provider of commercial services to the life science industry, has been certified as a Great Place to Work® by the global authority in workplace culture. EVERSANA ranked in the top 15 percent of more than 6,000 organizations worldwide who have submitted for the coveted certification. […]

Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicines

PALO ALTO, Calif. And CHICAGO – September 10, 2019 – Cognoa, a company at the forefront of pediatric behavioral health, and EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced a partnership to advance the industry standard by which digital medicines will be ordered, dispensed, and covered by […]

EVERSANA™ opens offices in Singapore & Mumbai as Asia Pacific commercial business rapidly expands

CHICAGO – August 6, 2019 – EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced the rapid expansion of its Asia Pacific business with the addition of two new offices in Singapore and Mumbai. The announcement comes as the company appoints a regional leadership team which will be […]

Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain

IRVINE, California, July 11, 2019 – Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) and EVERSANA™ have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution. The alliance will be designed to leverage EVERSANA’s position as the leading provider of commercial services addressing access, affordability and adherence challenges for cell and […]